# Tele-health Enabled Clinical Trial for COVID-19

> **NCT04489628** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University Hospitals Cleveland Medical Center**

## Conditions studied

- SARS-CoV Infection

## Interventions

- **DRUG:** Vitamin D3 or Placebo
- **DEVICE:** Doctella telehealth monitoring

## Key facts

- **NCT ID:** NCT04489628
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-08-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to overcome hurdles to study recruitment
- **Last updated:** 2022-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04489628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04489628, "Tele-health Enabled Clinical Trial for COVID-19". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04489628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*